Literature DB >> 28096092

Initiation of acute graft-versus-host disease by angiogenesis.

Katarina Riesner1, Yu Shi1, Angela Jacobi2, Martin Kräter3, Martina Kalupa1, Aleixandria McGearey1, Sarah Mertlitz1, Steffen Cordes1, Jens-Florian Schrezenmeier1,4, Jörg Mengwasser1, Sabine Westphal1, Daniel Perez-Hernandez4, Clemens Schmitt1,4, Gunnar Dittmar4, Jochen Guck2, Olaf Penack1.   

Abstract

The inhibition of inflammation-associated angiogenesis ameliorates inflammatory diseases by reducing the recruitment of tissue-infiltrating leukocytes. However, it is not known if angiogenesis has an active role during the initiation of inflammation or if it is merely a secondary effect occurring in response to stimuli by tissue-infiltrating leukocytes. Here, we show that angiogenesis precedes leukocyte infiltration in experimental models of inflammatory bowel disease and acute graft-versus-host disease (GVHD). We found that angiogenesis occurred as early as day+2 after allogeneic transplantation mainly in GVHD typical target organs skin, liver, and intestines, whereas no angiogenic changes appeared due to conditioning or syngeneic transplantation. The initiation phase of angiogenesis was not associated with classical endothelial cell (EC) activation signs, such as Vegfa/VEGFR1+2 upregulation or increased adhesion molecule expression. During early GVHD at day+2, we found significant metabolic and cytoskeleton changes in target organ ECs in gene array and proteomic analyses. These modifications have significant functional consequences as indicated by profoundly higher deformation in real-time deformability cytometry. Our results demonstrate that metabolic changes trigger alterations in cell mechanics, leading to enhanced migratory and proliferative potential of ECs during the initiation of inflammation. Our study adds evidence to the hypothesis that angiogenesis is involved in the initiation of tissue inflammation during GVHD.
© 2017 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28096092     DOI: 10.1182/blood-2016-08-736314

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

Review 1.  The Role of Circadian Rhythms in the Hypertension of Diabetes Mellitus and the Metabolic Syndrome.

Authors:  Björn Lemmer; Henrik Oster
Journal:  Curr Hypertens Rep       Date:  2018-05-05       Impact factor: 5.369

2.  Anti-vascular endothelial growth factor antibody monotherapy causes destructive advanced periodontitis in rice rats (Oryzomys palustris).

Authors:  J G Messer; E J Castillo; A M Abraham; J M Jiron; R Israel; J F Yarrow; S Thomas; M C Reynolds; R D Wnek; M Jorgensen; N Wanionok; C Van Poznak; I Bhattacharyya; D B Kimmel; J I Aguirre
Journal:  Bone       Date:  2019-11-07       Impact factor: 4.398

Review 3.  Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.

Authors:  Robert Zeiser; Bruce R Blazar
Journal:  N Engl J Med       Date:  2017-11-30       Impact factor: 91.245

Review 4.  Immune modulatory effects of statins.

Authors:  Robert Zeiser
Journal:  Immunology       Date:  2018-02-20       Impact factor: 7.397

5.  Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset.

Authors:  Jan Hülsdünker; Katja J Ottmüller; Hannes P Neeff; Motoko Koyama; Zhan Gao; Oliver S Thomas; Marie Follo; Ali Al-Ahmad; Gabriele Prinz; Sandra Duquesne; Heide Dierbach; Susanne Kirschnek; Tim Lämmermann; Martin J Blaser; Brian T Fife; Bruce R Blazar; Andreas Beilhack; Geoffrey R Hill; Georg Häcker; Robert Zeiser
Journal:  Blood       Date:  2018-02-20       Impact factor: 22.113

Review 6.  Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.

Authors:  Geoffrey D E Cuvelier; Michelle Schoettler; Nataliya P Buxbaum; Iago Pinal-Fernandez; Marc Schmalzing; Jörg H W Distler; Olaf Penack; Bianca D Santomasso; Robert Zeiser; Klemens Angstwurm; Kelli P A MacDonald; W Taylor Kimberly; Naomi Taylor; Ervina Bilic; Bernhard Banas; Maike Buettner-Herold; Namita Sinha; Hildegard T Greinix; Joseph Pidala; Kirk R Schultz; Kirsten M Williams; Yoshihiro Inamoto; Corey Cutler; Linda M Griffith; Stephanie J Lee; Stefanie Sarantopoulos; Steven Z Pavletic; Daniel Wolff
Journal:  Transplant Cell Ther       Date:  2022-05-31

7.  Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Laura F Newell; Todd E DeFor; Corey Cutler; Michael R Verneris; Bruce R Blazar; Jeff S Miller; Joseph H Antin; Alan Howard; Juan Wu; Margaret L MacMillan; Angela Panoskaltsis-Mortari; Daniel J Weisdorf; Shernan G Holtan
Journal:  Biol Blood Marrow Transplant       Date:  2019-11-10       Impact factor: 5.742

8.  Ruxolitinib Inhibits IFNγ Licensing of Human Bone Marrow Derived Mesenchymal Stromal Cells.

Authors:  Molly Mercedes Ryan; Mihir Patel; Keenan Hogan; Ariel Joy Lipat; Rafaela Scandolara; Rahul Das; Charles Bruker; Jacques Galipeau; Raghavan Chinnadurai
Journal:  Transplant Cell Ther       Date:  2021-02-04

9.  Ocular Graft-versus-Host Disease in a Chemotherapy-Based Minor-Mismatch Mouse Model Features Corneal (Lymph-) Angiogenesis.

Authors:  Uta Gehlsen; Daniela Stary; Martina Maass; Katarina Riesner; Gwen Musial; Michael E Stern; Olaf Penack; Philipp Steven
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

10.  Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.

Authors:  Jing Du; Ryan Flynn; Katelyn Paz; Hong-Gang Ren; Yuko Ogata; Qing Zhang; Philip R Gafken; Barry E Storer; Nathan H Roy; Janis K Burkhardt; Wendy Mathews; Jakub Tolar; Stephanie J Lee; Bruce R Blazar; Sophie Paczesny
Journal:  Blood       Date:  2018-01-18       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.